Healthcare Industry News:  Nastech Pharmaceutical 

Biopharmaceuticals Personnel

 News Release - February 14, 2008

Laureate Pharma Appoints Gary Swan as Vice President of Operations

Augments Senior Management Team with more than 30 Years Experience in Biopharmaceutical Manufacturing, Engineering, Technical Services and Validation

PRINCETON, N.J., Feb. 14 (HSMN NewsFeed) -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the appointment of Gary Swan as Vice President of Operations. In this newly created position, Mr. Swan will be responsible for leading Laureate's manufacturing operations, which include upstream processing, downstream processing, formulation and filling, facilities maintenance, warehouse operations, and environmental, health and safety regulations.

"We are delighted to welcome Gary to Laureate's senior leadership team," said Robert J. Broeze, Ph.D., President and CEO of Laureate. "With his strong background and extensive experience of more than 30 years in biopharmaceutical manufacturing operations, Gary will play a key leadership role in driving and managing Laureate's tremendous growth."

Gary's experience includes biopharmaceutical manufacturing, engineering, technical services, validation, and quality control. Most recently, Gary held the position of Senior Director of Manufacturing at Nastech Pharmaceuticals in Hauppauge, NY, a publicly traded biopharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. At Nastech, Gary directed the operations at two manufacturing sites in New York and Washington. In this capacity, he also led the planning and scheduling of the production of R&D, clinical, and licensed products. Prior to Nastech, Gary was the Vice President of Operations at VI Technologies in Melville, NY, a publicly traded biopharmaceutical company with a focus on development and manufacturing of virus-inactivated blood products and the purification of proteins from blood components. At VI, Gary was responsible for strategic planning and daily operation of a 100,000 SF sterile product biopharmaceutical facility with a staff of 200. Gary has a BS in Biology from Auburn University, Auburn, AL.

About Laureate Pharma, Inc.

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. Laureate Pharma, Inc. is a partner company of Safeguard Scientifics, Inc. (NYSE: SFE; www.safeguard.com), which provides growth capital for entrepreneurial and innovative technology and life sciences companies through expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings. For more information, contact Michael Cavanaugh, Vice President Sales, Marketing, and Business Development at (609) 919-3400 or info@laureatepharma.com, or visit www.laureatepharma.com.


Source: Laureate Pharma

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.